Physician profile
Michelle Ribas
NPI 1790060697
$21,591.65
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,457 · 2020: $7,639 · 2021: $544 · 2022: $717 · 2023: $934 · 2024: $3,191 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,036 · Travel and Lodging: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,035.71 |
| Travel and Lodging | $1,198.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,819.90 | 2019-2024 | |
| Biotissue Holdings INC. | $4,964.26 | 2021-2024 | |
| Organogenesis INC. | $178.44 | 2020-2025 | Cygnus Dual, Puraply Wound Matrix, Puraply |
| Davol INC. | $151.76 | 2020-2024 | Phasix Mesh |
| Sanofi-Aventis U.S. LLC | $121.83 | 2019 | |
| Ethicon US, LLC | $116.80 | 2019-2023 | Enseal |
| Acell, INC. | $80.25 | 2019-2020 | |
| Mimedx Group, INC. | $70.25 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $39.27 | 2022 | |
| Hologic Sales and Service, LLC | $29.46 | 2024 | Coolseal Generator |
| Smith+Nephew, INC. | $19.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Ribas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.